Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 2.75p
   
  • Change Today:
      0.000p
  • 52 Week High: 14.13p
  • 52 Week Low: 1.90p
  • Currency: UK Pounds
  • Shares Issued: 132.35m
  • Volume: 0
  • Market Cap: £3.64m
  • RiskGrade: 435

Valirx Overview

ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Registrars: Capita Registrars

Key Personnel

CEO: Suzanne Dilly
CFO: Gerald Desler
Non-Executive Chairman: Kevin Cox
Non-Executive Director & Chairman: Martin Gouldstone
Non-Executive Dir: Adrian de Courcey , Martin Lampshire

Contact Details

Address: Stonebridge House, Chelmsford Road, Hatfield Heath, United Kingdom, CM22 7BD
Website: http://www.valirx.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BLH13C52

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Valirx Market Data

Currency UK Pounds
Share Price 2.75p
Change Today 0.000p
% Change 0.00 %
52 Week High 14.13p
52 Week Low 1.90p
Volume 0
Shares Issued 132.35m
Market Cap £3.64m
RiskGrade 435

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
24.59% below the market average24.59% below the market average24.59% below the market average24.59% below the market average24.59% below the market average
1.96% above the sector average1.96% above the sector average1.96% above the sector average1.96% above the sector average1.96% above the sector average
Price Trend
93.5% below the market average93.5% below the market average93.5% below the market average93.5% below the market average93.5% below the market average
81.13% below the sector average81.13% below the sector average81.13% below the sector average81.13% below the sector average81.13% below the sector average
Income Not Available
Growth Not Available

Valirx Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

Valirx Key Personnel

CFO Gerald Desler
CEO Suzanne Dilly

Top of Page